| Abstrakt: |
Objective: This meta-analysis is aimed to quantify the findings of different meta-analyses performed on the association of hepatic and gastrointestinal complications and corona virus diesease (COVID-19) severity. Methods: Four databases i.e., PubMed, Google Scholar, Cochrane, and Web of science were used for the systematic search of the literature from January 2020 till July 2021. "Quality of Reporting of Meta-analyses (QUOROM) checklist was used to examine the comprehensiveness of reporting in the meta-analysis. Sixteen systematic review and meta-analysis studies met inclusion criteria. Results: Pooled results indicated that diarrhea was a significant symptom in COVID-19 patients (OR=2.70, 95% CI 1.16 to 6.29, p-value 0.020) along with abdominal pain (OR=3.87, 95% CI 2.86 to 5.23, p-value <0.001), nausea (OR=2.81, 95% CI 1.13 to 6.97, p-value 0.030), and vomiting (OR= 2.91, 95% CI 1.31 to 6.49, p-value 0.009). Pooled results also indicated a rise in alanine transaminase (ALT) level (OR= 3.81, 95% CI 1.71 to 8.45 p-value <0.001) and bilirubin level (OR=2.89, 95% CI 1.38 to 6.04, p-value <0.001) in COVID-19 patients. A significant association of aminotransferase (AST) with COVID-19 (OR=5.81, 95% CI 2.82 to 12, p-value <0.001) was also present. Conclusion: Severe acute respiratory syndrome coronavirus-2 can cause damage to the liver cells which may lead to an elevated level of inflammatory markers and liver enzymes (ALT/AST). [ABSTRACT FROM AUTHOR] |
